Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation

Authors: Franziska Boehm, Maria Martin, Rebecca Kesselring, Gabriela Schiechl, Edward K Geissler, Hans-Jürgen Schlitt, Stefan Fichtner-Feigl

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

Mice lacking Foxp3+ regulatory T (Treg) cells develop severe tissue inflammation in lung, skin, and liver with premature death, whereas the intestine remains uninflamed. This study aims to demonstrate the importance of Foxp3+ Treg for the activation of T cells and the development of intestinal inflammation.

Methods

Foxp3-GFP-DTR (human diphtheria toxin receptor) C57BL/6 mice allow elimination of Foxp3+ Treg by treatment with Dx (diphtheria toxin). The influence of Foxp3+ Treg on intestinal inflammation was tested using the CD4+ T-cell transfer colitis model in Rag−/− C57BL/6 mice and the acute DSS-colitis model.

Results

Continuous depletion of Foxp3+ Treg in Foxp3-GFP-DTR mice led to dramatic weight loss and death of mice by day 28. After 10 days of depletion of Foxp3+ Treg, isolated CD4+ T-cells were activated and produced extensive amounts of IFN-γ, IL-13, and IL-17A. Transfer of total CD4+ T-cells isolated from Foxp3-GFP-DTR mice did not result in any changes of intestinal homeostasis in Rag−/− C57BL/6 mice. However, administration of DTx between days 14 and 18 after T-cell reconstitution, lead to elimination of Foxp3+ Treg and to immediate weight loss due to intestinal inflammation. This pro-inflammatory effect of Foxp3+ Treg depletion consecutively increased inflammatory cytokine production. Further, the depletion of Foxp3+ Treg from Foxp3-GFP-DTR mice increased the severity of acute dSS-colitis accompanied by 80% lethality of Treg-depleted mice. CD4+ effector T-cells from Foxp3+ Treg-depleted mice produced significantly more pro-inflammatory cytokines.

Conclusion

Intermittent depletion of Foxp3+ Treg aggravates intestinal inflammatory responses demonstrating the importance of Foxp3+ Treg for the balance at the mucosal surface of the intestine.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Kim JM, Rasmussen JP, Rudensky AY: Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007, 8: 191-197. 10.1038/ni1428.CrossRefPubMed Kim JM, Rasmussen JP, Rudensky AY: Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol. 2007, 8: 191-197. 10.1038/ni1428.CrossRefPubMed
3.
go back to reference Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, deRoos P, Rudensky A, Sparwasser T: Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol. 2009, 183: 7631-7634. 10.4049/jimmunol.0804308.CrossRefPubMed Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, deRoos P, Rudensky A, Sparwasser T: Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol. 2009, 183: 7631-7634. 10.4049/jimmunol.0804308.CrossRefPubMed
4.
go back to reference Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336.CrossRefPubMed Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003, 4: 330-336.CrossRefPubMed
5.
go back to reference Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299: 1057-1061. 10.1126/science.1079490.CrossRefPubMed
6.
go back to reference Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003, 4: 337-342.CrossRefPubMed Khattri R, Cox T, Yasayko SA, Ramsdell F: An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003, 4: 337-342.CrossRefPubMed
7.
go back to reference Fontenot JD, Rasmussen JP, Williams LM, dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005, 22: 329-341. 10.1016/j.immuni.2005.01.016.CrossRefPubMed Fontenot JD, Rasmussen JP, Williams LM, dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005, 22: 329-341. 10.1016/j.immuni.2005.01.016.CrossRefPubMed
8.
go back to reference Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001, 27: 68-73.CrossRefPubMed Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001, 27: 68-73.CrossRefPubMed
9.
go back to reference Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002, 39: 537-545. 10.1136/jmg.39.8.537.CrossRefPubMedPubMedCentral Wildin RS, Smyk-Pearson S, Filipovich AH: Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2002, 39: 537-545. 10.1136/jmg.39.8.537.CrossRefPubMedPubMedCentral
10.
go back to reference Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009, 30: 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed Shevach EM: Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009, 30: 636-645. 10.1016/j.immuni.2009.04.010.CrossRefPubMed
11.
go back to reference Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003, 3: 521-533. 10.1038/nri1132.CrossRefPubMed Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003, 3: 521-533. 10.1038/nri1132.CrossRefPubMed
12.
go back to reference Izcue A, Coombes JL, Powrie F: Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006, 212: 256-271. 10.1111/j.0105-2896.2006.00423.x.CrossRefPubMed Izcue A, Coombes JL, Powrie F: Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006, 212: 256-271. 10.1111/j.0105-2896.2006.00423.x.CrossRefPubMed
13.
go back to reference Izcue A, Coombes JL, Powrie F: Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol. 2009, 27: 313-338. 10.1146/annurev.immunol.021908.132657.CrossRefPubMed Izcue A, Coombes JL, Powrie F: Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol. 2009, 27: 313-338. 10.1146/annurev.immunol.021908.132657.CrossRefPubMed
14.
go back to reference Izcue A, Powrie F: Special regulatory T-cell review: Regulatory T cells and the intestinal tract–patrolling the frontier. Immunology. 2008, 123: 6-10. 10.1111/j.1365-2567.2007.02778.x.CrossRefPubMedPubMedCentral Izcue A, Powrie F: Special regulatory T-cell review: Regulatory T cells and the intestinal tract–patrolling the frontier. Immunology. 2008, 123: 6-10. 10.1111/j.1365-2567.2007.02778.x.CrossRefPubMedPubMedCentral
15.
go back to reference Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F: Regulatory T cells and intestinal homeostasis. Immunol Rev. 2005, 204: 184-194. 10.1111/j.0105-2896.2005.00250.x.CrossRefPubMed Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F: Regulatory T cells and intestinal homeostasis. Immunol Rev. 2005, 204: 184-194. 10.1111/j.0105-2896.2005.00250.x.CrossRefPubMed
16.
go back to reference Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W: Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology. 1999, 117: 1078-1088. 10.1016/S0016-5085(99)70392-6.CrossRefPubMed Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W: Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology. 1999, 117: 1078-1088. 10.1016/S0016-5085(99)70392-6.CrossRefPubMed
17.
go back to reference Powrie F, Read S, Mottet C, Uhlig H, Maloy K: Control of immune pathology by regulatory T cells. Novartis Found Symp. 2003, 252: 92-98. discussion 98–105, 106–14CrossRefPubMed Powrie F, Read S, Mottet C, Uhlig H, Maloy K: Control of immune pathology by regulatory T cells. Novartis Found Symp. 2003, 252: 92-98. discussion 98–105, 106–14CrossRefPubMed
18.
go back to reference Read S, Powrie F: Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Curr Protoc Immunol. 2001,:Chapter 15:Unit 15 13 Read S, Powrie F: Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Curr Protoc Immunol. 2001,:Chapter 15:Unit 15 13
19.
go back to reference Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F: Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001, 182: 190-200. 10.1034/j.1600-065X.2001.1820115.x.CrossRefPubMed Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F: Control of intestinal inflammation by regulatory T cells. Immunol Rev. 2001, 182: 190-200. 10.1034/j.1600-065X.2001.1820115.x.CrossRefPubMed
20.
go back to reference Artis D: Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008, 8: 411-420. 10.1038/nri2316.CrossRefPubMed Artis D: Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008, 8: 411-420. 10.1038/nri2316.CrossRefPubMed
21.
go back to reference Barnes MJ, Powrie F: Regulatory T cells reinforce intestinal homeostasis. Immunity. 2009, 31: 401-411. 10.1016/j.immuni.2009.08.011.CrossRefPubMed Barnes MJ, Powrie F: Regulatory T cells reinforce intestinal homeostasis. Immunity. 2009, 31: 401-411. 10.1016/j.immuni.2009.08.011.CrossRefPubMed
22.
go back to reference Boden EK, Snapper SB: Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol. 2008, 24: 733-741. 10.1097/MOG.0b013e328311f26e.CrossRefPubMed Boden EK, Snapper SB: Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol. 2008, 24: 733-741. 10.1097/MOG.0b013e328311f26e.CrossRefPubMed
23.
go back to reference Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F: Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol. 2006, 177: 5852-5860.CrossRefPubMed Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F: Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol. 2006, 177: 5852-5860.CrossRefPubMed
24.
go back to reference Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R: Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005, 128: 1868-1878. 10.1053/j.gastro.2005.03.043.CrossRefPubMed Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R: Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005, 128: 1868-1878. 10.1053/j.gastro.2005.03.043.CrossRefPubMed
25.
go back to reference Holmen N, Lundgren A, Lundin S, Bergin AM, Rudin A, Sjovall H, Ohman L: Functional CD4+CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis. 2006, 12: 447-456. 10.1097/00054725-200606000-00003.CrossRefPubMed Holmen N, Lundgren A, Lundin S, Bergin AM, Rudin A, Sjovall H, Ohman L: Functional CD4+CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis. 2006, 12: 447-456. 10.1097/00054725-200606000-00003.CrossRefPubMed
26.
go back to reference Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S: Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010, 30: 80-89. 10.1007/s10875-009-9345-1.CrossRefPubMed Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S: Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol. 2010, 30: 80-89. 10.1007/s10875-009-9345-1.CrossRefPubMed
27.
go back to reference Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, Nakamura T, Koganei K, Fukushima T, Watanabe M: CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol. 2004, 173: 3119-3130.CrossRefPubMed Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, Nakamura T, Koganei K, Fukushima T, Watanabe M: CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol. 2004, 173: 3119-3130.CrossRefPubMed
28.
go back to reference Sitohy B, Hammarstrom S, Danielsson A, Hammarstrom ML: Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol. 2008, 151: 326-333. 10.1111/j.1365-2249.2007.03566.x.CrossRefPubMedPubMedCentral Sitohy B, Hammarstrom S, Danielsson A, Hammarstrom ML: Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol. 2008, 151: 326-333. 10.1111/j.1365-2249.2007.03566.x.CrossRefPubMedPubMedCentral
29.
go back to reference Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA: Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007, 13: 191-199. 10.1002/ibd.20053.CrossRefPubMed Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA: Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis. 2007, 13: 191-199. 10.1002/ibd.20053.CrossRefPubMed
30.
go back to reference Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA: Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol. 2009, 21: 281-285. 10.1016/j.coi.2009.05.007.CrossRefPubMedPubMedCentral Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA: Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol. 2009, 21: 281-285. 10.1016/j.coi.2009.05.007.CrossRefPubMedPubMedCentral
31.
go back to reference Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009, 10: 1000-1007. 10.1038/ni.1774.CrossRefPubMedPubMedCentral Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009, 10: 1000-1007. 10.1038/ni.1774.CrossRefPubMedPubMedCentral
32.
go back to reference Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, Papadakis KA: Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol. 2007, 125: 281-290. 10.1016/j.clim.2007.08.003.CrossRefPubMed Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, Papadakis KA: Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol. 2007, 125: 281-290. 10.1016/j.clim.2007.08.003.CrossRefPubMed
33.
go back to reference Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE: TNF down modulates the function of human CD4+CD25hi T-regulatory cells. Blood. 2006, 108: 253-261. 10.1182/blood-2005-11-4567.CrossRefPubMedPubMedCentral Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE: TNF down modulates the function of human CD4+CD25hi T-regulatory cells. Blood. 2006, 108: 253-261. 10.1182/blood-2005-11-4567.CrossRefPubMedPubMedCentral
34.
go back to reference Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med. 2007, 204: 33-39. 10.1084/jem.20061531.CrossRefPubMedPubMedCentral Nadkarni S, Mauri C, Ehrenstein MR: Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med. 2007, 204: 33-39. 10.1084/jem.20061531.CrossRefPubMedPubMedCentral
35.
go back to reference Ricciardelli I, Lindley KJ, Londei M, Quaratino S: Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology. 2008, 125: 178-183. 10.1111/j.1365-2567.2008.02839.x.CrossRefPubMedPubMedCentral Ricciardelli I, Lindley KJ, Londei M, Quaratino S: Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology. 2008, 125: 178-183. 10.1111/j.1365-2567.2008.02839.x.CrossRefPubMedPubMedCentral
36.
go back to reference Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A, Vitolo D, Boirivant M: Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis. 2008, 14: 662-668. 10.1002/ibd.20369.CrossRefPubMed Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A, Vitolo D, Boirivant M: Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis. 2008, 14: 662-668. 10.1002/ibd.20369.CrossRefPubMed
37.
go back to reference Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolaed L, Cho JH: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006, 314: 1461-1463. 10.1126/science.1135245.CrossRefPubMedPubMedCentral Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolaed L, Cho JH: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006, 314: 1461-1463. 10.1126/science.1135245.CrossRefPubMedPubMedCentral
38.
go back to reference Hue S, Ahern P, Buonocore S, Kullberg MC, Cuad J, McKenzie BS, Powrie F, Maloy KJ: Interleukin-23drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006, 203: 2473-2483. 10.1084/jem.20061099.CrossRefPubMedPubMedCentral Hue S, Ahern P, Buonocore S, Kullberg MC, Cuad J, McKenzie BS, Powrie F, Maloy KJ: Interleukin-23drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006, 203: 2473-2483. 10.1084/jem.20061099.CrossRefPubMedPubMedCentral
39.
go back to reference Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA: Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007, 132: 2359-2370. 10.1053/j.gastro.2007.03.104.CrossRefPubMed Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA: Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology. 2007, 132: 2359-2370. 10.1053/j.gastro.2007.03.104.CrossRefPubMed
40.
go back to reference Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cuad J, Powrie F, Cheever AW, Maloy KJ, Sher A: IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006, 203: 2485-2494. 10.1084/jem.20061082.CrossRefPubMedPubMedCentral Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cuad J, Powrie F, Cheever AW, Maloy KJ, Sher A: IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006, 203: 2485-2494. 10.1084/jem.20061082.CrossRefPubMedPubMedCentral
41.
go back to reference Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cuad J, Powrie F: Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006, 25: 309-318. 10.1016/j.immuni.2006.05.017.CrossRefPubMed Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cuad J, Powrie F: Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity. 2006, 25: 309-318. 10.1016/j.immuni.2006.05.017.CrossRefPubMed
42.
go back to reference Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F: Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 2008, 28: 559-570. 10.1016/j.immuni.2008.02.019.CrossRefPubMedPubMedCentral Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F: Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 2008, 28: 559-570. 10.1016/j.immuni.2008.02.019.CrossRefPubMedPubMedCentral
43.
go back to reference Liu G, Zhao Y: Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology. 2007, 122: 149-156. 10.1111/j.1365-2567.2007.02651.x.CrossRefPubMedPubMedCentral Liu G, Zhao Y: Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology. 2007, 122: 149-156. 10.1111/j.1365-2567.2007.02651.x.CrossRefPubMedPubMedCentral
Metadata
Title
Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation
Authors
Franziska Boehm
Maria Martin
Rebecca Kesselring
Gabriela Schiechl
Edward K Geissler
Hans-Jürgen Schlitt
Stefan Fichtner-Feigl
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-97

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.